Clinical trials
Sarcoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
160 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 17 |
| 2020 | 16 |
| 2021 | 16 |
| 2022 | 17 |
| 2023 | 12 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 160 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Grupo Espanol de Investigacion en Sarcomas | 6 |
| Henan Cancer Hospital | 5 |
| Herbert Irving Comprehensive Cancer Center | 5 |
| Shanghai Yunying Medical Technology | 5 |
| Sun Yat-sen University | 5 |
| Centre Leon Berard | 4 |
| Fudan University | 4 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 4 |
| Tianjin Medical University Cancer Institute and Hospital | 3 |
| AC Camargo Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 160 |
| Osteosarcoma | 13 |
| Breast Neoplasms | 12 |
| Liposarcoma | 10 |
| Leiomyosarcoma | 9 |
| Lymphoma | 9 |
| Ovarian Neoplasms | 9 |
| Stomach Neoplasms | 9 |
| Histiocytoma, Malignant Fibrous | 8 |
| Neoplasms | 8 |
Trials
Showing 51 to 75 of 160. Each trial links to its page on Pharma Observatory.
60 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.